Australian startup Gavl and Japanese startup Sora have closed early-stage funding rounds while Vertex Ventures, the venture capital (VC) unit of Singapore state investor Temasek Holdings, has launched a life sciences focused accelerator.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
